欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5509/001
药品名称Landiolol Hydrochloride Orpha-Devel 300 mg powder for solution for infusion
活性成分
    • Landiolol hydrochloride 300.0 mg
剂型Powder for solution for infusion
上市许可持有人Οrpha-Devel Handels und Vertriebs GmbH Wintergasse 85/1b 3002 Purkersdorf Niederoesterreich Austria
参考成员国 - 产品名称Netherlands (NL)
Landiolol Hydrochloride Orpha-Devel 300 mg poeder voor oplossing voor infusie
互认成员国 - 产品名称
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Belgium (BE)
许可日期2023/11/29
最近更新日期2024/11/07
药物ATC编码
    • C07AB14 landiolol
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase